| (a) |
Unless specifically otherwise provided in this subregulation (13), a bank that obtained the prior written approval of the Registrar to adopt the advanced IRB approach for the measurement of the bank's credit risk exposure in respect of positions held in the bank's banking book— |
| (i) |
shall continuously comply with the relevant minimum requirements specified in subregulation (11)(b) above and paragraph (b) below, and such further conditions as may be specified in writing by the Registrar; |
| (ii) |
shall comply with the relevant disclosure requirements specified in regulation 43(2); |
| (iii) |
shall categorise its exposures in accordance with the relevant requirements specified in subregulation (11)(c); |
| (iv) |
shall, subject to the provisions of paragraphs (b)(v) and (d) below, calculate its risk-weighted exposures in accordance with the relevant requirements, formulae and risk components specified in subregulations (11)(d) to (11)(p) above; |
| (v) |
shall apply the IRB approach for the measurement of the bank's exposure relating to a securitisation scheme, that is, a bank shall not use the IRB approach for the measurement of the bank's exposure in respect of a securitisation scheme unless the bank obtained the prior written approval of the Registrar to apply the IRB approach for the measurement of the bank's exposure to underlying credit exposure, provided that the bank shall in respect of the said securitisation exposures comply with the relevant requirements specified in subregulation (11)(b)(xii); |
| (vi) |
shall risk weight at 1250 per cent the relevant amounts or exposures specified in subregulations (6)(j) and (11)(q) above. |
[Regulation 23(13)(a)(vi) substituted by regulation 6(v) of Notice No. R. 297, GG 40002, dated 20 May 2016]
Medicines and Related Substances Act, 1965
